Reuters -- Patients with melanoma, a notoriously difficult to treat cancer of the skin, live longer when given Roche's drug Avastin, according to a scientific abstract from Europe's top cancer meeting.
Reuters -- Patients with melanoma, a notoriously difficult to treat cancer of the skin, live longer when given Roche's drug Avastin, according to a scientific abstract from Europe's top cancer meeting.
